Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Observational, Multicenter study on long-term Effectiveness and tolerability of aliROcumab (OMERO): an Italian real-life experience — Alberico L. Catapano (2025) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Observational, Multicenter study on long-term Effectiveness and tolerability of aliROcumab (OMERO): an Italian real-life experience
Shared by
Giancarlo Agnelli
University of Perugia
Observational, Multicenter study on long-term Effectiveness and tolerability of aliROcumab (OMERO): an Italian real-life experience
Article
2025
en
Authors
+3 more
AC
Alberico L. Catapano
AM
Aldo P. Maggioni
FR
Francesco Rossi
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2021
Observational multicenter study on effectiveness and tolerability of alirocumab in real world, The Omero study: Interim data from the fist 352 participants
Livia Pisciotta
,
Alberico L. Catapano
,
Aldo Maggioni
,
Francesco Rossi
,
Giampaolo Tirone
,
Lucia Notarianni
,
Giancarlo Agnelli
Article
2021
341 Observational multicentre study on effectiveness and tolerability of Alirocumab in real world, the OMERO study: interim data from the first 699 patients
Alberico L. Catapano
,
Aldo P. Maggioni
,
Francesco Rossi
,
Giampaolo Tirone
,
Lucia Notarianni
,
Giancarlo Agnelli
,
Arturo Cesaro
Article
2021
Italian multicenter observational study on real-life experience with alemtuzumab in naïve patients with aggressive multiple sclerosis
Lucia Moiola
,
Chiara Zanetta
,
Maria Di Cristinzi
,
Agostino Nozzolillo
,
Francesca Rinaldi
,
Laura Brambilla
,
Pietro Annovazzi
,
Giacomo Lus
,
Giorgia Puorro
,
Jessica Frau
,
Simona Malucchi
,
Assunta Bianco
,
Caterina Lapucci
,
Girolama Alessandra Marfia
,
Antonio Gallo
,
Raffaella Cerqua
,
Paola Cavalla
,
Massimo Filippi
Article
2024
Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study
Piero Barbanti
,
Gabriella Egeo
,
Stefania Proietti
,
Florindo d’Onofrio
,
Cinzia Aurilia
,
Cinzia Finocchi
,
Laura Di Clemente
,
Maurizio Zucco
,
Alberto Doretti
,
Stefano Messina
,
Massimo Autunno
,
Angelo Ranieri
,
Antonio Carnevale
,
Bruno Colombo
,
Massimo Filippi
,
Miriam Tasillo
,
Steno Rinalduzzi
,
Pietro Querzani
,
Giuliano Sette
,
Lorenzo Forino
,
Francesco Zoroddu
,
Article
2024
Effectiveness and safety of monthly versus quarterly fremanezumab for migraine prevention: An Italian, multicenter, real‐life study
Massimo Filippi
,
Laura Zanandrea
,
Roberta Messina
,
Ilaria Cetta
,
Federica Genovese
,
Simone Guerrieri
,
Fabrizio Vernieri
,
Claudia Altamura
,
Sabina Cevoli
,
Valentina Favoni
,
Bruno Colombo
Micaela Robotti
,
Alessandro Valenza
,
Cecilia Camarda
,
L. Borrello
,
Marco Aguggia
,
Giovanna Viticchi
,
Carlo Tomino
,
Giulia Fiorentini
,
Bianca Orlando
,
Stefano Bonassi
,
Paola Torelli
.jpg){kind=small}
Discussion(0)
No comments yet. Be the first to comment.